Neurocrine Bioscience buy tamam
Start price
25.08.15
/
50%
€40.64
Target price
21.09.15
€49.99
Performance (%)
23.60%
End price
21.09.15
€50.22
Summary
This prediction ended on 21.09.15 with a price of €50.22. The BUY prediction by tamam finished with a performance of 23.60%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neurocrine Bioscience | -2.546% | -2.546% | 7.429% | 16.894% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by tamam for this prediction
In the thread Neurocrine Bioscience diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 25.08.2015 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 55.42€ zu.
With Phase 3 data in tardive dyskinesia and Phase 1/2 data in Tourette syndrome with NBI-98854, Phase 3 data in endometriosis and Phase 2b data in uterine fibroids with elagolix, and Phase 1/2 data with NBI-77860 in congenital adrenal hyperplasia.
(Vom Mitglied beendet)
Stopped prediction by tamam for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€77.15
23.02.18
23.02.18
€112.75
04.11.21
04.11.21
6.34%
05.11.21
05.11.21
